Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Bimekizumab▼in Hidradenitis Suppurativa (HS)
14
Mins
January 2026
Experts explore 3-year clinical data on bimekizumab presented at the 2025 EADV and SHSA congresses, highlighting its durable and deep…
Read more
3
Mins
30 Oct 2025
Ruxolitinib Cream in Vitiligo Management: Real World Experience
Zink opened the session by recapping key efficacy data for ruxolitinib cream in non-segmental vitiligo from the TRuE-V1/2 registration…
6
Mins
30 Oct 2025
Clinical Perspectives on Photosensitivity and Photodiagnostics
Skin photosensitivity is defined as the cutaneous response to UV radiation (UVR) and/or visible light (VL). The Fitzpatrick Skin Phototype…
9
Mins
30 Oct 2025
Medical Management of Atopic Dermatitis in Pregnancy and Lactation
Atopic dermatitis (AD) is a common and chronic skin condition that can be significantly impacted by the physiological and immunological…
9
Mins
30 Oct 2025
Nail Psoriasis Treatment: A Narrative Review
Nail psoriasis remains a therapeutic challenge that is insufficiently addressed compared to skin and joint involvement. Treatment choices…
3
Mins
30 Oct 2025
Refractory Ulcerative Lupus Chilblains Treated with Deucravacitinib: A Case Report and Review of the Literature
Cutaneous lupus erythematosus (CLE) encompasses a group of autoimmune skin disorders that may occur independently or in association with…
9
Mins
30 Oct 2025
Nail Lichen Planus: A Comprehensive Review of Clinical Features, Histopathology, and Current Treatment
Nail lichen planus (NLP) is a chronic inflammatory disorder that can lead to irreversible damage, such as pterygium and anonychia. While…
3
Mins
17 Oct 2025
VLA-Induced Psoriasis Remission
Psoriasis, a prevalent chronic inflammatory skin disease affecting 2–3% of the global population,1 poses a significant therapeutic…
4
Mins
15 Oct 2025
Untangling Chronic Urticaria: Martin Metz
For me, there are two main takeaways from the study. The first is that we still don’t take CSU seriously enough. It is a debilitating…
13
Mins
14 Oct 2025
Advancing Skin Resilience Through Biology and Ecology
The skin, as the body’s largest organ, serves as a dynamic interface between internal systems and environmental influences. Beyond its…
5
Mins
10 Oct 2025
Gene–Environment Interactions in Dermatology: Sara J. Brown
Discover groundbreaking eczema research with Sara J. Brown, exploring skin organoids, genetics, and future breakthroughs in dermatology…
4
Mins
1 Oct 2025
Understanding Atopic Dermatitis: Astrid Haaskjold Lossius
Our aim is to improve treatment adherence and address psychological barriers such as steroid phobia by increasing knowledge and confidence around AD care…
6
Mins
22 Sep 2025
Managing Menopausal Skin: A Clinician's Review
Menopause is a natural biological transition in a woman’s life, marking the permanent cessation of menstruation, and…
3
Mins
11 Sep 2025
Development of Phage Therapies for Acne Vulgaris
Acne vulgaris, commonly known as acne, is a skin disease caused by the blockage of hair follicles, high keratin and sebum production in…
5
Mins
11 Sep 2025
Anti-IL-23 Blocks Pathogenic T Cells
Psoriasis affects 60 million people globally. It is an inflammatory skin condition that can significantly impact quality of life…
10
Mins
21 Aug 2025
The Evolving Atopic Dermatitis Treatment Landscape
Experts provide real-life insights and case examples of managing moderate-to-severe atopic dermatitis, sharing their treatment experience with lebrikizumab.
11
Mins
12 Jun 2025
Acne Treatment Review and Present Perspectives
Acne is a chronic inflammatory skin disease whose visible effects can have a significant psychological impact on patients. A multimodal…
29 May 2025
Retracted: Talokinumab in Moderate-to-Severe Atopic Dermatitis: The Latest Data
This article has now been retracted and a retraction statement has been published.
3
Mins
11 Mar 2025
Nemolizumab in Atopic Dermatitis
Nemolizumab is an anti-IL-31Rα monoclonal antibody that has demonstrated clinical efficacy in two global Phase III studies (ARCADIA-1 and…
30 Jan 2025
Vitiligo, Beyond White Patches
A review highlighting the need to improve vitiligo care through understanding the role of the JAK-STAT pathway, early diagnosis and…
17 Dec 2024
Tralokinumab in the Era of Disruption in Atopic Dermatitis
Gain valuable insights from three atopic dermatitis (AD) specialists who specifically consider one of the newest systemic therapies that targets the cytokine IL-13, a key cytokine involved in the pathogenesis of AD.
9
Mins
7 Nov 2024
Epigenetics to Reverse Skin Ageing
Epigenetic changes drive skin aging by silencing the expression of youthful genes. Experts discussed the discovery of epicelline, an…
11
Mins
7 Nov 2024
Vitiligo, Beyond White Patches
A review highlighting the need to improve vitiligo care through understanding the role of the JAK-STAT pathway, early diagnosis and…
6
Mins
7 Nov 2024
Mechanisms of Response to Bimekizumab for Psoriatic Disease
Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based on…
14
Mins
7 Nov 2024
Skin Microbiome and Acne
Marco Rocha, Thomas Dirschka, and Alison Layton discuss the current acne landscape, the potential role of the skin microbiome in acne…
10
Mins
7 Nov 2024
Therapies for AGA
Androgenetic alopecia (AGA) is the leading cause of hair loss in both men and women. Experts outline current and emerging therapies in the…
11
Mins
7 Nov 2024
Tralokinumab in Atopic Dermatitis
To discuss how biologics have disrupted clinical management of atopic dermatitis, and how tralokinumab fits into this paradigm, the EMJ sat…
4
Mins
7 Nov 2024
Advances in Treatment for Hair Loss Conditions
Hair loss is a common problem in clinical dermatology, with many aetiologies including but not limited to androgenetic alopecia…
8
Mins
7 Nov 2024
Update on Low-Molecular Weight Hyaluronic Acid
Hyaluronan, or hyaluronic acid (HA), is an extracellular matrix glycosaminoglycan distributed throughout the body, primarily found in…
5
Mins
7 Nov 2024
Autosomal Recessive Congenital Ichthyosis: Report of an Attenuated Phenotype
Congenital ichthyosis represents keratinisation disorders characterised by abnormal skin scaling across the entire body, leading to a red…
5
Mins
7 Nov 2024
Pigmented Variants of Basal Cell Carcinoma
Basal cell carcinoma (BCC) is a heterogeneous malignant neoplasm and can cause great morbidity as most occur in highly visible areas of…
31 Oct 2024
Tackling Infectious Diseases
This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.
9
Mins
23 Oct 2024
Interview: Chesahna Kindred
Now, as a practicing physician, I have no insecurities about being a woman in business, because in my training, I would be in a room with hundreds of women at the Women’s Dermatological Society.
14
Mins
12 Sep 2024
Clinical Practice Insights for Hyperpigmentation Treatment
Hyperpigmentation disorders, a group of common skin conditions characterised by darkened patches due to excess melanin production, affect…
12
Mins
9 Aug 2024
Reviewing Non-Scarring Alopecia in Women
Scalp hair is often regarded as a symbol of beauty and vitality across many cultures. Consequently, the loss of hair can significantly…
9
Mins
13 Jun 2024
Dermatitis Artefacta Treatment
Dermatitis artefacta (DA), also known as artefactual skin disease, is a rare psychocutaneous disorder characterised by…
9
Mins
13 Jun 2024
Caregiver Burden, Resilience, and Wellbeing in Cases of SCAR
Severe cutaneous adverse drug reactions (SCAR) are a group of rare but potentially life-threatening conditions that can occur in response…
5 Jun 2024
JAK Inhibitors: A New Frontier in Dermatology
JAK INHIBITORS have changed dermatology, and will continue to change dermatology in ways that no other class of drugs has…
1
Mins
12 Feb 2024
Author Response to: Letter To the Editor Concerning ‘Lichen Sclerosus in Prepubertal Males: Breaking the Paradigm’
The aim of our work was to underline that surgery can be applied as a first-line treatment. This was also the shared starting assumption…
15
Mins
30 Jan 2024
Exploring Advancements and Challenges in Adjuvant Melanoma Treatment
Melanoma of the skin is a common type of cancer that primarily affects younger patients. In Stage III melanoma, which does not involve…
1
Mins
25 Jan 2024
Letter To the Editor Concerning ‘Lichen Sclerosus in Prepubertal Males: Breaking the Paradigm’
We agree that the topic of treatment of penile lichen sclerosus in boys is important, and needs more attention in clinical research and…
7
Mins
23 Nov 2023
Bimekizumab 3-Year Efficacy in Patients with Moderate-to-Severe Plaque Psoriasis: Response Maintenance, Re-treatment, and Effect on High-Impact Areas
Psoriasis symptoms can be not only uncomfortable, irritating, and painful, but can also impact several aspects of a patients’ daily life…
8
Mins
23 Nov 2023
Secukinumab for Patients with Moderate-to-Severe Hidradenitis Suppurativa: Post Hoc Analyses of Efficacy Endpoints, Draining Tunnels, Skin Pain, and Work Productivity
Due to the clinical heterogenicity of HS, assessment of disease severity is complex, and over 20 different outcome measures have…
2
Mins
23 Nov 2023
Efficacy and Safety of Upadacitinib in a Phase II Randomised, Double-Blind, Dose-Ranging Study of Adults with Extensive Non-segmental Vitiligo
Vitiligo is an autoimmune skin disorder that causes depigmentation of the skin and/or leukotrichia of the hair, resulting from the…
10
Mins
23 Nov 2023
A New Landmark for Wellbeing in Psoriasis: The POSITIVE Study
Psoriatic disease is a chronic, inflammatory immune condition affecting more than 40 million individuals worldwide…
13
Mins
17 Nov 2023
Platelet-Rich Plasma Applications, The Past 5 Years
This review article aims to provide an overview of platelet-rich plasma’s applications and evidence over the past 5 years in randomised…
9
Mins
26 Oct 2023
Editor's Pick: Diagnostic Evaluation of Hair Loss: A Narrative Review
This review provides a systematic approach for dermatologists to use in order to accurately diagnose hair loss disorders…
10
Mins
12 Oct 2023
Patient Centricity in Skin Treatments: Global Meeting of Experts in Dermatology
During this symposium, global experts in dermatology gave a series of lectures focused on skin treatments and their benefits for patients…
5
Mins
5 Oct 2023
Mycosis Fungoides Palmaris et Plantaris Progressing to Complete Early-Stage Disease Improved with Phototherapy
Mycosis fungoides is the most common form of cutaneous T cell lymphoma. In this article, the authors describe a case of a 53-year-old…
8
Mins
5 Sep 2023
Editor’s Pick: Assessing the Relationship Between Vitiligo and Cardiovascular Disease Risk Factors
Vitiligo is an autoimmune disorder characterised by the loss of melanocytes, resulting in white, depigmented cutaneous macules…
6
Mins
9 Aug 2023
Collagen-Filler Injection Associated Dermopathy and COVID-19
COVID-19 and cosmetic skin-fillers are two prevalent topics of today’s medicine, yet their interaction is not sufficiently studied. This…
5
Mins
8 Aug 2023
Systemic Sclerosis Manifesting Post-Radiotherapy: A Case Report
Morphoea causes skin and subcutaneous tissue fibrosis, and can sometimes involve the fascia, muscle, or bone. Sclerosis usually begins as…
7
Mins
24 Jul 2023
Progressive Facial Hemiatrophy (Parry–Romberg Syndrome) Treated with Hyaluronic Acid Fillers
Parry–Romberg syndrome (PRS) is a rare neurocutaneous condition that can affect the skin, subcutaneous fat, muscle, and bone on one side…
11
Mins
15 Jun 2023
Elevating Aesthetics: Patient-Specific Treatment with Hyaluronic Acid Fillers to Improve Appearance and Psychosocial Wellbeing
This review of the ‘Elevating Aesthetics’ symposium held at the International Master Course on Aging Science (IMCAS) 2023 shares insights…
3
Mins
31 May 2023
Interview: Edel O’Toole
I was always interested in biology and science. As a child, I loved identifying wild flowers and this is not all that dissimilar to…
7
Mins
23 May 2023
Interview: Christopher Griffiths
There were actually two reasons. When I was about 4 years old, I was given a bird book by my parents and I memorised every bird…
3
Mins
16 May 2023
Cutaneous Squamous Cell Carcinoma of the Hand Presenting as Clinical Perineural Invasion
Cutaneous squamous cell carcinoma (SCC) contributes to 20% of non-melanoma skin cancers and early diagnosis is vital to reducing…
11
Mins
12 Apr 2023
IL-17 and -23 Inhibitors for the Treatment of Psoriasis
Psoriasis is a chronic inflammatory skin disorder affecting approximately 60 million people worldwide. The condition presents with rapid hyperproliferation and dysregulated differentiation of epidermal keratinocytes, manifesting clinically as salmon pink plaques with overlying silvery-white scale.
25 Nov 2022
Clinical Efficacy and Outcomes of Remibrutinib (LOU064) in Patients with Chronic Spontaneous Urticaria Inadequately Controlled with H1-Antihistamines: Findings from a Phase IIb Study
As part of the 31st European Academy of Dermatology and Venereology (EADV) Annual Congress held in Milan, Italy, and online, 7th–10th September 2022, five poster presentations outlined results from the Phase IIb study of remibrutinib (LOU064) in patients with chronic spontaneous urticaria inadequately controlled with H1-antihistamines.
11
Mins
14 Nov 2022
An Overview of the EORTC-CLTG 2022 Congress
This year’s European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Tumours Group (CLTG) Annual Meeting was held in Madrid, Spain. Presentations covered a broad range of topics in the field of cutaneous lymphomas, from molecular mechanisms, through diagnostics and prediction of prognosis, to skin-directed and targeted therapies, combination therapies, and patient-reported outcomes.
6
Mins
20 Oct 2022
Photoprotection and the Science Behind Skin Healing
Sun exposure can lead to tanning, but also to skin damage due to the actions of ultraviolet A and B, visible light, and infrared radiation. One result of sun exposure is field cancerisation (FC), the precursor to actinic keratosis (AK), which in turn is a risk factor for, most notably, squamous cell carcinoma.
6
Mins
20 Oct 2022
Clinical Efficacy and Outcomes of Remibrutinib (LOU064) in Patients with Chronic Spontaneous Urticaria Inadequately Controlled with H1-Antihistamines: Findings from a Phase IIb Study
Chronic spontaneous urticaria (CSU) is characterised by the spontaneous occurrence of wheals (hives) and/or angioedema for ≥6 weeks.1 CSU can persist for several years and is associated with severe pruritus. Skin mast cell activation in CSU occurs via Type I autoallergy driven by IgE to autoallergens, and a Type IIb autoimmune response due to mast cell-targeted autoantibodies against IgE or high-affinity IgE receptor.
5
Mins
20 Oct 2022
Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: Primary Endpoint Analysis from the SUNSHINE and SUNRISE Phase III Trials
The primary endpoint analyses from the SUNSHINE and SUNRISE Phase III trials of secukinumab in moderate-to-severe hidradenitis suppurativa (HS) were featured in an oral presentation as part of the late-breaking news session at the 31st annual European Academy of Dermatology and Venereology (EADV) congress. Known collectively as the SUNNY trials, the SUNSHINE and SUNRISE studies represent the largest Phase III trials conducted in HS to date.
5
Mins
4 Jul 2022
Editor's Pick: Pemphigus Vulgaris and Pemphigus Foliaceus: A Single-Centre Comparative Study in Rabat, Morocco
Pemphigus is a group of rare autoimmune blistering diseases affecting the skin and mucous membranes. Pemphigus foliaceus (PF)…
9
Mins
16 Jun 2022
Beyond Aesthetics: Hyaluronic Acid Fillers as a Therapeutic Treatment
Any filler injection requires a bespoke treatment approach and a thorough anatomy knowledge to minimise procedural risks and achieve…
10
Mins
30 May 2022
A Retrospective Database Cohort Study Evaluating the Association Between Immune Suppressive Therapy and the Development of Cancer in Patients with Atopic Dermatitis Within UK Primary Care
Atopic dermatitis (AD) is the most common inflammatory skin condition, affecting 11–20% of children and 5–10% of adults…
7
Mins
9 May 2022
Trichotillomania with Giant Gastric Trichobezoar in a Female Child: A Case Report
Trichotillomania is defined by the Diagnostics and Statistic Manual of Mental Disorders (DSM-5) as an individual repetitively pulling…
5
Mins
2 May 2022
Varicella Zoster Reactivation Following mRNA Vaccination: Two Case Reports and a Review of Cutaneous Adverse Events of COVID-19 Vaccines
Varicella Zoster reactivation and cutaneous reaction as a mRNA vaccine side effect following COVID 19 vaccination…
4
Mins
28 Apr 2022
Case Report of Epstein–Barr Virus-Induced Autoimmune Vitiligo in Nigeria
Vitiligo is an acquired skin depigmenting disorder resulting from melanocytes loss in the epidermis, associated with an autoimmune aetiopathophysiology. However, there are limited data about the association between vitiligo and Epstein–Barr virus (EBV).
5
Mins
11 Apr 2022
Severe Sunburn-Like Adverse Cutaneous Drug Reaction in a Patient on Treatment with Rifaximin: A Rare Case of Acute Phototoxic Drug Reaction
Drug-induced photosensitivity is an adverse cutaneous reaction caused by a simultaneous exposure to potentially photosensitising drugs (via topical application or parenteral administration) and ultraviolet (UV) radiation or visible light.
6
Mins
2 Mar 2022
Revolution in Photoprotection: How to Recommend and Adapt Photoprotection According to Skin Phototype and Dermatoses
The solar spectrum is composed of various wavelengths of electromagnetic radiation that can penetrate the skin to different levels: the longer…
4
Mins
21 Feb 2022
Paget Disease of Skin Secondary to Urothelial Carcinoma
Currently, the exact mechanism underlying EMPD is unknown, but two widely known theories exist, namely the epidermotropic and transformation theories.
5
Mins
21 Feb 2022
Treatment with Hyaluronic Acid Injections in a Patient with Craniosynostosis
A case of a 25-year-old White female left with residual bone deformity after surgical correction of craniosynostosis during childhood…
5
Mins
3 Feb 2022
Latest Highlights on Biologic Treatments for Psoriasis and Psoriatic Arthritis from the EADV 2021
The latest research on autoimmune skin disease has studied the efficacy and safety characterisation of guselkumab (GUS), a human monoclonal…
10
Mins
3 Feb 2022
Diving Deep: Harnessing the Potential of the IL-23 Pathway
Strober began by summarising his opinion on the key characteristics of anti-IL-23 therapies that support their efficacy for inducing…
6
Mins
17 Jan 2022
Dermatophyte Monitoring in an Iranian Training Dermatology Hospital
Dermatophytes are the keratinophilic moulds living on the superficial layer of human and animal skin and are transmitted by direct and…
4
Mins
11 Nov 2021
Eleven Myths on Nail Melanoma
A number of misconceptions prevail in nail melanoma. This short essay tries to clarify some of these issues.
4
Mins
11 Nov 2021
Interview: Peter Lio
Interviewing Peter Lio, Clinical Assistant Professor of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine
8
Mins
11 Nov 2021
The Benefits of Achieving Complete Control in Patients with Chronic Spontaneous Urticaria
The latest international guidelines on urticaria were published in September as a joint initiative from the European Academy of…
10
Mins
11 Nov 2021
Tailored Injection Techniques in the Mid- and Lower Face Using a Multilayering Approach
Recent years have witnessed significant advances in the understanding of facial anatomy. Extensive studies have uncovered the arrangement of soft-tissue layers underlying the skin and their mobility during expression. Meanwhile, increasing awareness of the facial vascular network has laid the foundation for lower risk cosmetic procedures.
3
Mins
11 Nov 2021
Interview: Roxana Daneshjou
An interview with Roxana Daneshjou, Clinical Scholar of Dermatology, Stanford University, California, USA.
7
Mins
11 Nov 2021
Mosaicism in Tuberous Sclerosis Complex: A Case Report, Literature Review, and Original Data from Danish Hospitals
Tuberous sclerosis complex (TSC) is an autosomal dominant hereditary disease with hamartomatous growths in multiple organs due to…
9
Mins
11 Nov 2021
Emerging Treatment Regimens in Psoriasis: Are There Advantages Over Current Biologic Therapies?
Psoriasis is a chronic inflammatory skin condition that impacts patients’ quality of life and has large economic consequences…
10
Mins
22 Oct 2021
Patient-Reported Outcomes with Monoclonal Antibody Therapies in Patients with Moderate-to-Severe Plaque Psoriasis
Richard B. Warren highlighted Psoriasis Symptoms and Impacts Measure (P-SIM) responses from the Phase III BE VIVID trial in patients…
10
Mins
20 Oct 2021
Efficacy and Safety of Monoclonal Antibody Therapies in Patients with Moderate-to-Severe Plaque Psoriasis
In the late-breaking research sessions, Reich presented BE RADIANT, the first Phase III trial to compare inhibition of IL-17A and IL-17F…
6
Mins
15 Oct 2021
Where Do We Begin? The Key Role of the IL-23 Pathway in Psoriasis and Psoriatic Arthritis
This Janssen-sponsored live satellite symposium, entitled ‘Where do we begin? The key role of the IL-23 pathway in psoriasis and psoriatic…
9
Mins
17 Jun 2021
Pioneering Best Practices in Atopic Dermatitis: Results from the Quality of Care Initiative
Pioneering global best practices in atopic dermatitis (AD) and implementing them in the clinic are important steps towards optimising patient care…
11
Mins
17 May 2021
Botulinum Toxins in Medical and Cosmetic Dermatology
Botulinum neurotoxins (BoNTs) are derived from Clostridium botulinum, a gram-positive anaerobe. While there are seven subtypes of BoNT (A to G), only A…
5
Mins
3 May 2021
Prominent Cutaneous Manifestation of COVID-19: A Case Report
The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen and the subsequent coronavirus disease (COVID-19) mainly affect the lung…
10
Mins
29 Mar 2021
Advancing Breakthrough Innovative Treatment in Paediatric Dermatitis and Various Skin Disorders
Eczematous dermatitis (or eczema) includes AD, CD, and DD. This inflammatory skin reaction presents as erythema, vesicles, desquamation…
15
Mins
23 Mar 2021
The Treatment Landscape of Atopic Dermatitis: Interviews with Three Consultant Dermatologists
Atopic dermatitis (AD), sometimes referred to as ‘atopic eczema’, is a common, chronic, pruritic, Type II inflammatory skin disease which is associated…
12
Mins
23 Mar 2021
Transient Cutaneous Alterations of the Newborn
At birth, the skin of the newborn suddenly comes into contact with the extrauterine world: a dry and aerobic environment.1 Newborn skin is 40–60%…
14
Mins
15 Mar 2021
Syphilis Diagnosis and Treatment: State of The Art
Syphilis is a chronic bacterial infection caused by Treponema pallidum subspecies pallidum, known by clinicians for hundreds of years and with more than 5 million new cases diagnosed every year worldwide…
11
Mins
25 Feb 2021
Clinical Considerations Based On 5-Year Efficacy and Safety Data for the IL-23p19 Inhibitor Tildrakizumab
The indicative scaly, erythematous plaques of plaque psoriasis arise because of abnormal interactions between immune system cells and epidermal…
9
Mins
18 Feb 2021
Biological and Clinical Impacts of Ultraviolet-A on the Skin: New Insights
Terrestrial solar UVR consists of UVA (320–400 nm) and UVB (280–320 nm; typically around 295–320nm because of attenuation by the ozone…
11
Mins
10 Feb 2021
Long-term Efficacy and Safety of Tildrakizumab: 5-year Results from the reSURFACE 1 and 2 Phase III Trials in Patients with Moderate-to-severe Plaque Psoriasis
Psoriasis, a chronic systemic inflammatory disease with skin manifestations, can be an impediment to daily life. Accordingly…
8
Mins
15 Dec 2020
The Other Side of the Moon: A Clinical Dialogue on the IL-23 Pathway
Prof Reich began by highlighting how insights into the pathophysiology of psoriasis have led to the development and expansion of cytokine-targeted…
6
Mins
15 Dec 2020
Latest Highlights on Biologic Treatments for Psoriasis and Psoriatic Arthritis from EADV 2020
The VOYAGE 1 trial1 was a placebo- and active-controlled Phase III study to evaluate long-term efficacy and safety of the IL-23p19 inhibitor guselkumab…
8
Mins
15 Dec 2020
Bimekizumab Efficacy and Safety in Patients with Moderate-to-Severe Plaque Psoriasis
Psoriasis is a Th17-driven disease, with both IL-17A and IL-17F playing a pivotal role in its pathogenesis.2,3 BKZ is a monoclonal IgG1 antibody…
9
Mins
15 Dec 2020
Editor’s Pick: Managing Chronic Urticaria: Quo Vadis?
Chronic urticaria (CU) is one of the most commonly diagnosed skin conditions. CU is characterised by the presence of recurrent wheals and/or angioedema…
8
Mins
15 Dec 2020
Impaired Mitochondrial and Metabolic Function of Fibroblasts Derived from Patients with Recessive Dystrophic and Junctional Epidermolysis Bullosa
Recessive dystrophic epidermolysis bullosa (RDEB) and junctional EB (JEB) are inherited disorders characterised by fragility and blistering of epithelial…
11
Mins
15 Dec 2020
Management of Plaque Psoriasis: A Review and Comparison of IL-23 Inhibitors
With the recent advancements of biologic therapies that block IL-23, there is increasing need for analysis of which biologics are most efficacious…
4
Mins
15 Dec 2020
Case Report: Suspected Case of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Overlap Due to Ursodeoxycholic Acid
Stevens–Johnson syndrome and toxic epidermal necrolysis are well-known severe cutaneous adverse reactions, with >100 medications previously implicated…
8
Mins
17 Aug 2020
Differential Diagnosis of Nail Psoriasis and Onychomycoses: A Report Based on 40 Years of Specialised Nail Consultations
Ungual psoriasis and onychomycosis are common nail diseases. Despite their different aetiology and course, surprisingly they have much in common.
6
Mins
31 Jul 2020
Clinical Cases in Dermatology: Modern Management of Acne, Actinic Keratosis, and Atopic Dermatitis
This clinical dermatology report examines six short case studies of patients diagnosed with acne vulgaris, actinic keratosis (AK), and atopic dermatitis (AD)…
Loading posts...
« Previous
1
…
12
13
14
15
16
…
30
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View